Elevance Health <ELV.N>: Leerink Partners Raises Target Price to $395 From $364
ELV•Related News
TKO director Nick Khan disposes of USD 1.88 million in common shares
TKO•
BioXcel Therapeutics director Susan E. Atkins files initial beneficial ownership statement
BTAI•
Disc Medicine COO Jonathan Yu reports sale of 804 common shares worth $66,451.57
IRON•
Tectonic Therapeutic CSO Peter McNamara reports TECX common share disposal worth $1,505 on Aug. 12
TECX•
Nasdaq Trade Halt Continues <UCFIW.O> Reason Not Available at 08:30 PM
UCFIW•